To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

IA injection of US-approved viscosupplements safe and effective at 26 weeks in knee OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2015

IA injection of US-approved viscosupplements safe and effective at 26 weeks in knee OA

Vol: 4| Issue: 8| Number:9| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials

J Pain Res. 2015 May 7;8:217-28

Contributing Authors:
V Strand LF McIntyre WR Beach LE Miller JE Block

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

29 randomized controlled trials, with a total of 4,886 patients were included in this meta-analysis to analyze the safety and efficacy of US-approved viscosupplements in symptomatic knee osteoarthritis (OA) treatment. Results indicated that intra-articular injection of viscosupplements may be safe and effective through 26 weeks, as they resulted in large treatment effects for knee pain and functio...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue